Perfil
Simon Fricker worked as a Director-Biology at AnorMED, Inc. and as a Vice President-Research at Phio Pharmaceuticals Corp.
He graduated and earned a doctorate degree from the University of Warwick.
Antiguos cargos conocidos de Simon Fricker.
| Empresas | Cargo | Fin |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Chief Tech/Sci/R&D Officer | 01/12/2022 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Corporate Officer/Principal | - |
Formación de Simon Fricker.
| University of Warwick | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Empresas privadas | 1 |
|---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
- Bolsa de valores
- Insiders
- Simon Fricker
